The 1999 NIH Consensus: Setting Adequate Intakes for Omega-6 and Omega-3 Fatty Acids

Background

In April 1999, an international group of researchers convened at the National Institutes of Health in Bethesda for a three-day workshop dedicated to a foundational question: how much omega-6 and omega-3 fatty acid should people actually consume? Published as a meeting report by Simopoulos, Leaf, and Salem in the Annals of Nutrition and Metabolism, this workshop brought together investigators specializing in infant nutrition, cardiovascular disease, and the then-emerging field of essential fatty acids and mental health.

The gathering was genuinely international, drawing scientists from academia, government, and industry across Australia, Canada, Denmark, France, Italy, Japan, Norway, Switzerland, the UK, and the US, alongside representatives from the USDA, the Pan American Health Organization/WHO, and the FAO. Rather than issuing a single-author opinion, the workshop's recommendations represent a genuine working-group consensus, reached through round-table presentations and discussion over three days.

Meeting Snapshot

Meeting	NIH Workshop on Essentiality and RDIs for ω-6/ω-3 FAs	Location & date	The Cloisters, NIH, Bethesda, MD — April 7–9, 1999
Sponsors	NIAAA-NIH, ODS-NIH, Center for Genetics Nutrition and Health, ISSFAL	Scope	Infant nutrition, cardiovascular disease, mental health
Format	Round-table presentations and discussion over 3 days	Participants	International — academia, government, industry (10 countries)
Key output	Adequate Intake (AI) recommendations for adults and infant formula	Agencies represented	USDA, PAHO/WHO, FAO

The Central Recommendation: Rebalance, Don't Just Add

The workshop's most consequential conclusion wasn't simply “eat more omega-3” — it was that omega-6 intake needs to come down at the same time omega-3 intake goes up. This matters because linoleic acid (LA, the parent omega-6 compound) and alpha-linolenic acid (LNA, the parent omega-3 compound) compete for the same desaturase enzyme in the body. When the diet is dominated by LA-rich vegetable oils — corn, safflower, and soybean oil, a hallmark of Western diets — that competition skews conversion toward arachidonic acid (AA) and its eicosanoid products, which the working group identified as a driver of adverse health effects when present in excess.

In other words, simply adding omega-3 supplementation on top of an already omega-6-heavy diet was, in the group's assessment, an incomplete strategy. The consensus called for two simultaneous, interdependent changes: reducing dietary LA from vegetable oils, and increasing LNA together with EPA and DHA.

Adequate Intakes (AI) for Adults

The working group concluded there wasn't yet enough data to set formal Dietary Reference Intakes (DRIs), but there was sufficient evidence to recommend Adequate Intakes (AI) — reference values based on observed intake levels in healthy populations. These are summarized below, based on a 2,000 kcal/day diet.

Fatty Acid	g/day (2,000 kcal diet)	% of Energy
Linoleic acid (LA)	4.44	2.0%
LA — upper limit	6.67	3.0%
α-Linolenic acid (LNA)	2.22	1.0%
DHA + EPA	0.65	0.3%
DHA, at least	0.22	0.1%
EPA, at least	0.22	0.1%
Trans fatty acids — upper limit	2.00	1.0%
Saturated fat — upper limit	—	< 8.0%

An upper limit (UL) for LA of 6.67 g/day (3.0% of energy) was also specified, alongside a recommendation that saturated fat stay under 8% of energy and that trans fatty acids be avoided in the food supply from hydrogenation or reused frying oils.

Pregnancy and Lactation

For pregnant and lactating women, the workshop endorsed the same adult AI values with one addition: ensuring a DHA intake of at least 300 mg/day, reflecting DHA's specific role in fetal and infant neural development during this period.

Adequate Intake for Infant Formula

Given the large number of premature infants worldwide and the relatively low global rate of breastfeeding, the working group placed particular emphasis on infant formula composition — aiming for formula-fed infants to achieve growth and neural development comparable to breastfed infants. The recommended composition, expressed as a percentage of total fatty acids, is shown below.

Fatty Acid	Percent of Total Fatty Acids
Linoleic acid (LA)	10.00%
α-Linolenic acid (LNA)	1.50%
Arachidonic acid (AA)	0.50%
DHA	0.35%
EPA — upper limit	< 0.10%

The group endorsed adding both AA and DHA to all infant formulas, while capping EPA below 0.10% of fatty acids — higher levels were felt to potentially antagonize AA and interfere with infant growth.

Why This Matters for Practice

For anyone counseling on nutrition or supplement use, this 1999 consensus remains a useful historical anchor point: it's one of the earliest formal, multi-stakeholder efforts to set numeric intake targets for omega-6 and omega-3 fatty acids, rather than relying on vague “eat more fish” guidance. Its core insight — that the omega-6:omega-3 ratio matters as much as absolute omega-3 intake — has proven durable and continues to inform more recent reviews and recommendations on this topic.

It's worth noting this is a meeting report summarizing workshop consensus, not a systematic review or clinical trial — the recommendations reflect the best available evidence and expert judgment of the participants in 1999, and dietary reference values in this area have continued to evolve since.

Takeaway

This NIH-sponsored workshop established some of the earliest consensus Adequate Intake values for omega-6 and omega-3 fatty acids in adults, pregnant/lactating women, and infant formula, built around a central principle that remains influential today: optimal omega-3 benefits depend on simultaneously reducing excess dietary omega-6, not simply adding omega-3 on top of an already imbalanced diet.

Reference

Simopoulos AP, Leaf A, Salem N Jr. Essentiality of and Recommended Dietary Intakes for Omega-6 and Omega-3 Fatty Acids. Ann Nutr Metab. 1999;43:127–130.

Omega-6 and Omega-3 Adequate Intakes — 1999 NIH Workshop Report Summary